Latest / Stock Movers / Kingfisher Soars, Roche's Shot, Ericsson's Slip
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios. Podcasts. Radio. News. The Stock Movers Report.
- 0:10Speaker 1: Your roundup of companies making moves in the stock market.
- 0:13Speaker 1: Harnessing the power of Bloomberg data.
- 0:16Speaker 2: Let's take a look at some of the stocks on
- 0:17Speaker 2: the move today here in Europe. I'm Caroline Hipka with
- 0:20Speaker 2: Lizzie Burden and we're joined by Bloomberg's breaking news editor,
- 0:23Speaker 2: Louise Moon. Louise, good to speak to you. Kingfisher, let's
- 0:26Speaker 2: start with the retailer fixing up its guidance. How's it doing?
- 0:31Speaker 3: It has, yes. It's lifted its four-year guidance beyond expectations. So,
- 0:35Speaker 3: some quite positive news there. This was in tandem with
- 0:38Speaker 3: their first half earnings. Those beat estimates mostly down to
- 0:42Speaker 3: gains in Screwfix, one of the brands that they have,
- 0:45Speaker 3: as well as overseas gains, notably Poland and Spain. So,
- 0:49Speaker 3: they all did very well. B & Q, which is
- 0:52Speaker 3: what it's kind of more known for in the UK,
- 0:55Speaker 3: sales are more flat there. So, gains really in Screwfix,
- 0:58Speaker 3: Poland and Spain. Also, e-commerce doing very well. That's been
- 1:01Speaker 3: a big focus for Kingfisher.
- 1:03Speaker 1: And its brands.
- 1:04Speaker 3: And then crucially, it was saying that tradespeople are really
- 1:08Speaker 3: boosting demand rather than or more than DIY retailers, which
- 1:13Speaker 3: is just quite an interesting point. So, it's for your guidance.
- 1:16Speaker 3: analysts saying that the results are much stronger than expected.
- 1:19Speaker 3: Morgan Stanley, in particular, saying they think that's driven more
- 1:24Speaker 3: by strategy than by pricing. And they've increased their price
- 1:27Speaker 3: target as a result. So, shares up the most in
- 1:30Speaker 3: a year, up about 11% in morning trading.
- 1:33Speaker 2: And Louise, earlier on in the day, we were playing
- 1:35Speaker 2: the interview with the CEO of Novo, talking obviously about
- 1:38Speaker 2: weight loss drugs in part.
- 1:40Speaker 3: Roche, interestingly, looking to compete as well in the weight
- 1:43Speaker 3: loss space.
- 1:43Speaker 1: Tell us more.
- 1:44Speaker 3: Yeah, trying to get in on that weight loss drug market, compete,
- 1:47Speaker 3: as you say, with Novo, with Eli Lilly, all those
- 1:50Speaker 3: big names there. So, the news this morning related to
- 1:54Speaker 3: that is that they've had data for a mid-stage trial
- 1:57Speaker 3: of their experimental obesity shot. So, it came in quite positive.
- 2:01Speaker 3: It cut blood sugar and weight in the patients who
- 2:05Speaker 3: were part of the test. They were type 2 diabetes
- 2:07Speaker 3: patients who were overweight or obese. And if you look
- 2:12Speaker 3: at that, it's quite interesting. So, those who received the
- 2:14Speaker 3: highest dose lost an average of 15.5% of their body
- 2:18Speaker 3: weight in that trial. So, positive, although shares actually little change.
- 2:23Speaker 3: Analysts saying that, yes, it's positive. But they're waiting for
- 2:26Speaker 3: the phase three trial data. So, to see how it performs.
- 2:30Speaker 3: And they're not getting the hopes up as of yet,
- 2:32Speaker 3: but seem to be positive and making inroads into that market.
- 2:36Speaker 2: Okay. That's interesting in terms of the drug makers. What
- 2:38Speaker 2: about Ericsson on the wrong end of an analyst downgrade? Yeah.
- 2:44Speaker 3: So, also Morgan Stanley this morning have downgraded it to
- 2:47Speaker 3: underweight from equal weight, saying that their margins are inflecting
- 2:51Speaker 3: to the downside. They see limited room for revenue growth. So,
- 2:56Speaker 3: noting kind of an overall flatter market, also saying that
- 2:59Speaker 3: revenue from North America started to turn after quite a
- 3:02Speaker 3: few years of good growth there. And they actually prefer
- 3:05Speaker 3: Nokia within that space. Ericsson has already been struggling a bit.
- 3:11Speaker 3: They've seen some weaker demand, as has the whole market,
- 3:13Speaker 3: from phone companies. There was anticipated spending on 5G networks
- 3:18Speaker 3: that failed to materialize, and that's been weighing on them. So,
- 3:20Speaker 3: they've been cutting jobs, cutting costs. And then, yeah, this
- 3:24Speaker 3: Morgan Stanley downgrade kind of adding to that. If you
- 3:29Speaker 3: look now at the analyst ratings, they've got actually 10
- 3:32Speaker 3: holds and nine sells and only seven buys. So, it
- 3:34Speaker 3: kind of indicates where the mood at is there with
- 3:36Speaker 3: attitude so shares relatively um relatively flat uh but they've
- 3:43Speaker 3: been kind of slipping more recently um and then yeah
- 3:45Speaker 3: we've we've had this this downgrade as.
- 3:46Speaker 1: Well The Stock Movers Report from Bloomberg Radio. Check back
- 3:52Speaker 1: with us throughout the day for the latest roundup of
- 3:54Speaker 1: companies making news on Wall Street. And for the latest
- 3:57Speaker 1: market-moving headlines, listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,
- 4:03Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 4:06Speaker 1: Business app.